Diferencia entre revisiones de «Aminoglycosides»
Sin resumen de edición |
|||
| Línea 8: | Línea 8: | ||
*Nephro and oto toxic. Risk of neuromuscular blockade. | *Nephro and oto toxic. Risk of neuromuscular blockade. | ||
*Can precipitate crisis in patients with [[myasthenia gravis]] | *Can precipitate crisis in patients with [[myasthenia gravis]] | ||
* Include [[gentamicin]] and [[tobramycin]] | *Include [[gentamicin]] and [[tobramycin]] | ||
==See Also== | ==See Also== | ||
| Línea 15: | Línea 15: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Revisión del 00:44 10 jul 2017
Background
- Used (alone or with beta-lactam) to treat serious infections due to gram-negative bacilli, e.g.:
- Ill patient with pyelonephritis
- Meningitis (due to pseudomonas, acinetobacter)
- Peritoneal dialysis-associated peritonitis
- Bacterial endocarditis
- Used +/- beta-lactam
- Nephro and oto toxic. Risk of neuromuscular blockade.
- Can precipitate crisis in patients with myasthenia gravis
- Include gentamicin and tobramycin
See Also
References
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||